Leads Biolabs

About:

Leads Biolabs is a biotechnology company that develops treatment outcomes and access for patients worldwide.

Website: http://www.leadsbiolabs.com

Top Investors: Shenzhen Capital Group, Cowin Venture, Loyal Valley Capital, Lapam Capital, Dyee Capital

Description:

Leads Biolabs is a biotechnology company that develops treatment outcomes and access for patients worldwide. The company is committed to researching and developing novel antibody-based therapeutics in oncology and immunological disease areas in order to meet patients' global unmet needs. On the monoclonal antibody and bispecific antibody development technology platform, they already have a robust research and development pipeline with over ten innovative cancer immunotherapy antibody projects. Leads Biolabs was founded in 2014 and is headquartered in China.

Total Funding Amount:

$100M

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2014-01-01

Contact Email:

wlzb(AT)leadsbiolabs.com

Founders:

Lai Shoupeng, Xiaoqiang Kang

Number of Employees:

1-10

Last Funding Date:

2021-10-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai